Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
Titel:
Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer
Auteur:
Knappskog, Stian Chrisanthar, Ranjan Løkkevik, Erik Anker, Gun Østenstad, Bjørn Lundgren, Steinar Risberg, Terje Mjaaland, Ingvil Leirvaag, Beryl Miletic, Hrvoje Lønning, Per E